Jason Zhang

Equity Research Analyst

Mr. Zhang joined Burrill & Company as an Equity Research Analyst in the Company’s Merchant Banking Group in January 2012. Based on the East Coast, he covers the biotech/biopharmaceutical sector, in which he has extensive experience. Most recently, Mr. Zhang has been a research analyst covering the biotech/biopharmaceutical sector for BMO Capital Markets, Prudential Equity Group, Independent Research Group and Stephens, Inc. Mr. Zhang has earned many awards for his equity research and stock recommendations, including No. 3 Stock Picker in the Biotechnology Industry in the 2009 Financial Times StarMine Analyst Awards, No. 5 in Biotechnology in the 2009 Wall Street Journal Best On The Street stock analysts competition and No. 5 (139% return) in the 2007 Zacks Top Ten Analysts Survey (across all industries).
He received his Ph.D. in Cell, Molecular & Neurosciences/Botanic Sciences from the University of Hawaii, an MBA from Indiana University’s Kelly School of Business, an MS from China Agricultural University and a BA from Huazhong (Central China) Agricultural University. He conducted research in the field of signal transduction as a postdoctoral fellow at Indiana University’s School of Medicine and Oncology and as a postdoctoral scientist at Eli Lilly & Company.